Perspective Therapeutics (CATX) announced the appointment of Juan Graham as the Company’s Chief Financial Officer, CFO, effective as of January 6, 2025. In connection with the transition, Jonathan Hunt will no longer serve as CFO but will continue serving as the Company’s Chief Accounting Officer, CAO. Graham served as Chief Financial Officer of FibroGen (FGEN)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Perspective Therapeutics management to meet with Truist
- Perspective Therapeutics price target lowered to $9 from $17 at B. Riley
- Perspective Therapeutics price target lowered to $16 from $25 at RBC Capital
- Perspective Therapeutics downgraded to Neutral from Buy at BofA
- Perspective Therapeutics price target lowered to $16 from $22 at Oppenheimer